- Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor
Takahito Hara et al, 2020, Biochemistry and Biophysics Reports CrossRef - Efferocytosis: An accomplice of cancer immune escape
Hui Qiu et al, 2023, Biomedicine & Pharmacotherapy CrossRef - Targeting BRD3 eradicates nuclear TYRO3-induced colorectal cancer metastasis
Pei-Ling Hsu et al, 2023, Science Advances CrossRef - Targeting Tyrosine Kinases in Ovarian Cancer: Small Molecule Inhibitor and Monoclonal Antibody, Where Are We Now?
Aimee Rendell et al, 2022, Biomedicines CrossRef - TAM receptors Tyro3 and Mer as novel targets in colorectal cancer
Robin Schmitz et al, 2016, Oncotarget CrossRef - Targeting TAM to Tame Pancreatic Cancer
Mitchell S. von Itzstein et al, 2020, Targeted Oncology CrossRef - Intracellular catalase activity instead of glutathione level dominates the resistance of cells to reactive oxygen species
Meng-Xin Zhao et al, 2019, Cell Stress and Chaperones CrossRef - TAM Receptor Tyrosine Kinases in Cancer Drug Resistance
Mikaella Vouri et al, 2017, Cancer Research CrossRef - Endocytic trafficking of GAS6–AXL complexes is associated with sustained AKT activation
Agata Poświata et al, 2022, Cellular and Molecular Life Sciences CrossRef - TAM family kinases as therapeutic targets at the interface of cancer and immunity
Deborah DeRyckere et al, 2023, Nature Reviews Clinical Oncology CrossRef - Circ_0000467 Exerts an Oncogenic Role in Colorectal Cancer via miR-330-5p-Dependent Regulation of TYRO3
Yubao Huang et al, 2022, Biochemical Genetics CrossRef - TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinoma
Kara M. Ruicci et al, 2020, Journal of Experimental & Clinical Cancer Research CrossRef - Antitumour effects of a solid lipid nanoparticle loaded with gemcitabine and oxaliplatin on the viability, apoptosis, autophagy, and Hsp90 of ovarian cancer cells
Ashwaq A. Al-Mutairi et al, 2022, Journal of Microencapsulation CrossRef - TYRO3: A potential therapeutic target in cancer
Pei-Ling Hsu et al, 2019, Experimental Biology and Medicine CrossRef - Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment
Kayla V. Myers et al, 2019, Molecular Cancer CrossRef - TAM family proteins and therapy resistance
Nellie K. McDaniel et al, 2020, Improving the Therapeutic Ratio in Head and Neck Cancer CrossRef - A microRNA‐7/growth arrest specific 6/TYRO3 axis regulates the growth and invasiveness of sorafenib‐resistant cells in human hepatocellular carcinoma
Tasnuva D. Kabir et al, 2018, Hepatology CrossRef - Identification of Potentially Therapeutic Target Genes in Ovarian Cancer via Bioinformatic Approach
Li Chengzhang et al, 2021, 2021 IEEE 9th International Conference on Bioinformatics and Computational Biology (ICBCB) CrossRef - Tyro3 carboxyl terminal region confers stability and contains the autophosphorylation sites
Hanshuang Shao et al, 2017, Biochemical and Biophysical Research Communications CrossRef - Identification of signalling pathways activated by Tyro3 that promote cell survival, proliferation and invasiveness in human cancer cells
Nour Al Kafri et al, 2021, Biochemistry and Biophysics Reports CrossRef - LeMeDISCO is a computational method for large-scale prediction & molecular interpretation of disease comorbidity
Courtney Astore et al, 2022, Communications Biology CrossRef - The Emerging Role of TYRO3 as a Therapeutic Target in Cancer
Sherri Smart et al, 2018, Cancers CrossRef - High-throughput organo-on-pillar (high-TOP) array system for three-dimensional ex vivo drug testing
Hye Ryeong Jun et al, 2023, Biomaterials CrossRef - G-749 Promotes Receptor Tyrosine Kinase TYRO3 Degradation and Induces Apoptosis in Both Colon Cancer Cell Lines and Xenograft Mouse Models
Hae Dong Kim et al, 2021, Frontiers in Pharmacology CrossRef